Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced ...

Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...

In a 36-week study, semaglutide was found to aid in weight loss for people with schizophrenia without worsening psychotic ...

A European health authority has found that medications containing semaglutide—such as Ozempic, Wegovy, and Rybelsus—can ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

Diabetic weight-loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...

Eight individuals, including employees from Dr Reddy's Lab, have been arrested for stealing Semaglutide powder worth over Rs.

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.

A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...